Journey Medical DERM 深 滬
已收盤 11-06 16:00:00 美东时间
4.47
+0.170
+3.95%
華盛通- 最 高4.54
- 今 開4.31
- 成交量 15.31万股
- 最 低 4.31
- 昨 收 4.30
- 總市值 1.26亿
- 52周最高 9.555
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 4.25
- 委 比 -40.19%
- 總股本 2822.44万
- 歷史最高 10.20
- 量 比 0.82
- 振 幅 5.35%
- 歷史最低 1.02
- 每 手 1
- 風險率 1.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
Journey Medical Corporation will release its third quarter 2026 financial results after U.S. markets close on November 12, 2026. A conference call and audio webcast will be held at 4:30 p.m. ET on the same day to discuss the results and provide a corporate update. Interested parties can join the call by dialing 1-866-777-2509 (domestic) or 1-412-317-5413 (international), or register online via the provided link. A live webcast will also be availa...
11-05 13:30
Journey Medical收跌7.35%，成交额70.5万美元
11月3日，Journey Medical（DERM）收跌7.35%，报4.79美元，成交额70.5万美元，市值1.35亿美元。 行情数据 • 开盘价：5.2...
11-03 07:51
美股大行评级 | 潜在涨幅101.01%！Stifel上调ORIC Pharmaceuticals目标价至18美元，维持"买入"评级
今日重点评级关注：Stifel：维持ORIC Pharmaceuticals"买入"评级，目标价从14美元升至18美元；花旗：维持Liberty Energy"买入"评级，目标价从27.5美元升至28美元
10-27 12:30
Journey Medical收跌1%，成交额58.85万美元
10月27日，Journey Medical（DERM）收跌1%，报4.97美元，成交额58.85万美元，市值1.4亿美元。 行情数据 • 开盘价：4.97美元...
10-27 06:52
HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Journey Medical (NASDAQ:DERM) with a Buy and maintains $13 price target.
10-26 18:28
Journey Medical收跌3.12%，成交额92万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:56
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Journey Medical Corporation (NASDAQ: DERM) announced that its CEO, Claude Maraoui, will attend two investor conferences in September 2026. The first is the Lake Street Capital Markets 10th Annual BIG10 Conference on September 10 in New York City, featuring 1x1 meetings. The second is the H.C. Wainwright 28th Annual Global Investment Conference on September 14, also in NYC, with a presentation and 1x1 meetings. A webcast of the H.C. Wainwright pre...
09-08 20:05
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
Longeveron Inc. appoints Nirav Jhaveri as Chief Financial Officer, bringing over 25 years of experience in biotech finance and capital markets. Jhaveri succeeds Marie Washburn, who returns to her role as Corporate Controller. The company highlights Jhaveri's expertise in advancing stem cell therapy, particularly its lead product laromestrocel, which is in Phase 2b trials for HLHS. Jhaveri aims to support the company's growth and operational effic...
08-19 20:05
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15
B. Riley Securities analyst Mayank Mamtani reiterates Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $12 to $15.
08-13 21:15
